H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)

February 6, 2025 6:41 AM

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $102.00 price target on Viking Therapeutic (NASDAQ: VKTX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found